The company, which is engaged in developing women’s health products targeting fertility control, gynecological disorders and oncology, was spun off earlier in 2008 from the San Antonio-based Southwest Foundation for Biomedical Research (SFBR).
Klaus Nickisch, Evestra’s chief scientific officer and general manager of Evestra GmbH, said: “With a presence in Berlin, Evestra is now well positioned to maximize its strengths on both sides of the Atlantic. Both cities and countries provide us with great advantages in scientific capabilities, proven biomedical business leadership and markets in female healthcare.”
John Kerr, chairman of Evestra’s board, said: “Our presence in Europe is a key step forward in Evestra’s development. It demonstrates the continued momentum of this company, following on the spinoff from SFBR and our recent very successful private offering to investors. We expect to announce additional important milestones in the coming months.”